This result was consistent with a previous report that identified a hidden TAD within EZH2 that can be unlocked by cancer-specific EZH2-phosphorylation, resulting in structural conformation changes that mediate interactions with active transcription machinery (57). This evidence concerns the gene EZH2 and cancer.